Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Jun 14 2022

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 14-Jun-2022 titled Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases